Studies using the ZoltanCAP® have shown a clinically significant improvement in patient status.
The graphs show a summary of the results.
Patients, seniors over 60 years of age, who had been taking antihypertensive medications for over one year were randomly assigned to a control and a ZoltanCAP® group. The ZoltanCAP® group had a significant drop in systolic and diastolic blood pressures. See:
Impact of an Electronic Compliance Aid on Long-Term Blood Pressure Control J. Clin Pharmacol 32:277-283
The small drop in blood pressure in the control group may also be attributable to improved compliance,
since both groups were lectured as one group, regarding the importance of medication compliance.